SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-04-000288
Filing Date
2004-02-17
Accepted
2004-02-17 12:06:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g-lajollapharma12312003.txt SC 13G 53697
  Complete submission text file 0000913414-04-000288.txt   55925
Mailing Address 45 FREMONT ST SAN FRANCISCO CA 94105
Business Address 45 FREMONT ST 17TH FL SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

IRS No.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 0000

Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44849 | Film No.: 04605569
SIC: 2836 Biological Products, (No Diagnostic Substances)